Company ERYTECH Pharma LIQUIDNET SYSTEMS
Equities
FR0011471135
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thibaut du Fayet
CEO | Chief Executive Officer | 56 | 23-06-22 |
Eric Soyer
DFI | Director of Finance/CFO | 57 | 23-06-22 |
Pascal Birman
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-22 |
Cindy Fevre
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-22 |
Céline Breda
CTO | Chief Tech/Sci/R&D Officer | 54 | 23-06-22 |
Karine Charton
PRN | Corporate Officer/Principal | - | 23-06-22 |
General Counsel | - | 23-06-22 | |
Human Resources Officer | - | 23-06-22 | |
Jérôme Bailly
PRN | Corporate Officer/Principal | 45 | 23-06-22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 23-06-22 | |
Hilde Windels
BRD | Director/Board Member | 59 | 23-06-22 |
Gil Beyen
BRD | Director/Board Member | 62 | 23-06-22 |
Martine George
BRD | Director/Board Member | 76 | 23-06-22 |
Director/Board Member | 66 | 23-06-22 | |
Didier Hoch
CHM | Chairman | 68 | 23-06-22 |
Leila Nicolas
BRD | Director/Board Member | - | 23-06-22 |
Robert Sebbag
BRD | Director/Board Member | 73 | 23-06-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,137,712 | 10,660,161 ( 95.71 %) | 270 ( 0.002429 %) | 95.71 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
250 | 0.00% | 813 $ |
Company contact information
![address ERYTECH Pharma](https://cdn.zonebourse.com/static/address/35055710.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.56B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |